MX2021011152A - Bacterias oxidantes de amoniaco para el tratamiento del acne. - Google Patents

Bacterias oxidantes de amoniaco para el tratamiento del acne.

Info

Publication number
MX2021011152A
MX2021011152A MX2021011152A MX2021011152A MX2021011152A MX 2021011152 A MX2021011152 A MX 2021011152A MX 2021011152 A MX2021011152 A MX 2021011152A MX 2021011152 A MX2021011152 A MX 2021011152A MX 2021011152 A MX2021011152 A MX 2021011152A
Authority
MX
Mexico
Prior art keywords
acne
oxidizing bacteria
ammonia oxidizing
treatment
subject
Prior art date
Application number
MX2021011152A
Other languages
English (en)
Inventor
Larry Weiss
David R Whitlock
Spiro Jamas
Original Assignee
Aobiome Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/882,284 external-priority patent/US9738870B2/en
Application filed by Aobiome Llc filed Critical Aobiome Llc
Publication of MX2021011152A publication Critical patent/MX2021011152A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81Preparation or application process involves irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87Application Devices; Containers; Packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporciona un método para tratamiento de un trastorno de la piel, por ejemplo, acné, por ejemplo acné común, en un sujeto. El método comprende administrar, por ejemplo, aplicar, por ejemplo, administrar de manera tópica, bacterias oxidantes de amoniaco, por ejemplo, una preparación que comprende bacterias oxidantes de amoniaco, a la superficie de un sujeto. También se proporcionan preparaciones que comprenden bacterias oxidantes de amoniaco para tratamiento de tales trastornos de la piel, por ejemplo, acné, por ejemplo acné común, en un sujeto.
MX2021011152A 2015-07-02 2018-01-08 Bacterias oxidantes de amoniaco para el tratamiento del acne. MX2021011152A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562188343P 2015-07-02 2015-07-02
US201562189105P 2015-07-06 2015-07-06
US14/882,284 US9738870B2 (en) 2014-04-15 2015-10-13 Ammonia oxidizing bacteria for treatment of acne

Publications (1)

Publication Number Publication Date
MX2021011152A true MX2021011152A (es) 2021-10-22

Family

ID=88967788

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000274A MX2018000274A (es) 2015-07-02 2016-07-01 Bacterias oxidantes de amoniaco para el tratamiento del acne.
MX2021011152A MX2021011152A (es) 2015-07-02 2018-01-08 Bacterias oxidantes de amoniaco para el tratamiento del acne.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018000274A MX2018000274A (es) 2015-07-02 2016-07-01 Bacterias oxidantes de amoniaco para el tratamiento del acne.

Country Status (15)

Country Link
EP (2) EP3943160A1 (es)
JP (3) JP2018524351A (es)
KR (1) KR20180022934A (es)
CN (1) CN108367029A (es)
AU (2) AU2016288256B2 (es)
BR (1) BR112018000056A2 (es)
CA (1) CA2991170A1 (es)
HK (1) HK1255251A1 (es)
IL (2) IL256617B (es)
MX (2) MX2018000274A (es)
PH (1) PH12018500015A1 (es)
RU (1) RU2753125C2 (es)
SG (1) SG10201913983TA (es)
WO (1) WO2017004557A1 (es)
ZA (2) ZA201800030B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017332347A1 (en) * 2016-09-21 2019-04-18 Aobiome Llc Ammonia oxidizing microorganisms for use and delivery to the intranasal system
US20200206278A1 (en) * 2017-07-18 2020-07-02 Aobiome Llc Ammonia oxidizing microorganisms for the treatment of pulmonary hypertension
AR112393A1 (es) * 2017-07-18 2019-10-23 Aobiome Llc Microorganismos oxidantes de amoníaco para el tratamiento de cefaleas
WO2019018425A1 (en) * 2017-07-18 2019-01-24 Aobiome Llc AMMONIA-OXIDIZING MICROORGANISMS FOR INJECTION USE AND ADMINISTRATION
WO2019126711A1 (en) * 2017-12-22 2019-06-27 Aobiome Llc Veterinary use and delivery of ammonia oxidizing microorganisms
KR20200144116A (ko) 2018-04-16 2020-12-28 온퀄리티 파마슈티컬스 차이나 리미티드 암 치료의 부작용을 예방하거나 치료하기 위한 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
US5314542A (en) 1993-08-06 1994-05-24 Precision Aquarium Testing, Inc. Nitrosomonas preservation and reactivation for aquaria
FR2774674B1 (fr) 1998-02-10 2000-03-24 Atochem Elf Sa Procede de preparation d'une solution aqueuse de peroxyde d'hydrogene directement a partir d'hydrogene et d'oxygene et dispositif permettant sa mise en oeuvre
EA005649B1 (ru) * 2000-08-11 2005-04-28 Дэвид Р. Уитлок Композиции, содержащие аммиакокисляющие бактерии, увеличивающие продуцирование окиси азота и предшественников окиси азота, и способы их использования
BR0306868A (pt) * 2002-01-11 2005-04-12 David R Whitlock Composições incluindo bactérias oxidando amonìaco e métodos para usar as mesmas
BRPI0414813A (pt) * 2003-09-26 2006-11-14 David R Whitlock método para o uso de bactéria que oxidam a amÈnia
CN1997731A (zh) * 2003-09-26 2007-07-11 大卫·R·怀特洛克 使用氨氧化细菌的方法
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
EP4249001A3 (en) * 2009-08-21 2023-11-29 Novan, Inc. Topical gels
US8591876B2 (en) * 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
CA2949833A1 (en) * 2014-05-22 2015-11-26 Aobiome Llc Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria
RU2613708C2 (ru) * 2014-11-07 2017-03-21 Бюджетное учреждение высшего образования Ханты-Мансийского автономного округа - Югра "Ханты-Мансийская государственная медицинская академия" Способ лечения угревой болезни

Also Published As

Publication number Publication date
ZA202211665B (en) 2024-02-28
AU2016288256A1 (en) 2018-01-25
IL256617A (en) 2018-02-28
PH12018500015A1 (en) 2018-07-09
RU2753125C2 (ru) 2021-08-11
CN108367029A (zh) 2018-08-03
WO2017004557A1 (en) 2017-01-05
EP3316900A1 (en) 2018-05-09
SG10201913983TA (en) 2020-03-30
IL256617B (en) 2021-10-31
EP3316900B1 (en) 2021-09-01
JP2018524351A (ja) 2018-08-30
BR112018000056A2 (pt) 2018-09-04
MX2018000274A (es) 2018-05-22
JP2023162452A (ja) 2023-11-08
AU2022275473A1 (en) 2023-01-05
AU2016288256B2 (en) 2022-08-25
RU2018103906A (ru) 2019-08-05
ZA201800030B (en) 2023-12-20
RU2018103906A3 (es) 2019-12-24
JP2021050238A (ja) 2021-04-01
HK1255251A1 (zh) 2019-08-09
EP3943160A1 (en) 2022-01-26
IL286488A (en) 2021-10-31
KR20180022934A (ko) 2018-03-06
CA2991170A1 (en) 2017-01-05

Similar Documents

Publication Publication Date Title
ZA202211665B (en) Ammonia oxidizing bacteria for treatment of acne
WO2018112365A3 (en) Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
MY196418A (en) Therapeutically Active Compounds and Their Methods of use
MX2023001527A (es) Compuestos con actividad inductora de ferroptosis y metodos de uso de estos.
MX2017004471A (es) Compuestos de triazolopiridina y métodos para el tratamiento de fibrosis cística.
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
MX2015000131A (es) Metodo y aparato para tratamiento dermatologico.
MY188139A (en) Sodium channel modulators for the treatment of pain
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
PH12017500933A1 (en) Sublingual administration of riluzole
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
MX365366B (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
PH12017500934A1 (en) Sublingual formulation of riluzole
SG10201804034QA (en) Methods for treating hypotension
MX2016016388A (es) Uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de pulmon de celula no pequeña y/o cancer de pulmon de celula pequeña.
MX344281B (es) Uso de paulownin y/o extractos de madera de paulownia para preparar composiciones topicas para el tratamiento de la celulitis.
NZ720273A (en) Preparations and methods for treating a gd2 positive cancer
MX2018011379A (es) Tratamiento del prurito uremico.
MX2016002307A (es) Tratamiento para el cancer.
MX2019001337A (es) Métodos para tratar y prevenir efectos secundarios por tratamiento de cáncer.
EP3443090A4 (en) USE OF MIR-223-3P AS CANCER THERAPEUTIC AND METHOD FOR THE TREATMENT OF CANCER THEREWITH
SG10201806381VA (en) Treatment of h. pylori infections using mtan inhibitors
MX2018005083A (es) Métodos para el tratamiento de acné comun mediante el uso de composiciones tópicas de dapsona.
UA108444C2 (uk) Спосіб лікування вугрової хвороби шкіри обличчя за індріксоном
NZ750581A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy